Adrian von Witzleben

565 total citations
33 papers, 315 citations indexed

About

Adrian von Witzleben is a scholar working on Oncology, Otorhinolaryngology and Immunology. According to data from OpenAlex, Adrian von Witzleben has authored 33 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Otorhinolaryngology and 8 papers in Immunology. Recurrent topics in Adrian von Witzleben's work include Cancer Immunotherapy and Biomarkers (13 papers), Head and Neck Cancer Studies (11 papers) and Immune Cell Function and Interaction (5 papers). Adrian von Witzleben is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Head and Neck Cancer Studies (11 papers) and Immune Cell Function and Interaction (5 papers). Adrian von Witzleben collaborates with scholars based in Germany, United Kingdom and United States. Adrian von Witzleben's co-authors include Simon Laban, Christian H. Ottensmeier, Chuan Wang, Natalia Savelyeva, Thomas F.E. Barth, Regine Mayer‐Steinacker, Markus Schultheiß, Alexandra von Baer, Thomas K. Hoffmann and Silke Brüderlein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Adrian von Witzleben

28 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian von Witzleben Germany 11 132 129 91 87 70 33 315
Albiruni R. Abdul Razak Canada 4 102 0.8× 140 1.1× 110 1.2× 123 1.4× 22 0.3× 14 340
Christine Fritz Switzerland 8 65 0.5× 81 0.6× 55 0.6× 50 0.6× 25 0.4× 11 214
Changwen Zhai China 12 91 0.7× 60 0.5× 205 2.3× 40 0.5× 33 0.5× 22 407
Olga L. Bohn United States 11 141 1.1× 81 0.6× 77 0.8× 59 0.7× 39 0.6× 18 352
Paola Poletti Italy 11 218 1.7× 128 1.0× 29 0.3× 57 0.7× 55 0.8× 18 335
Laura Suárez–Fernández Spain 12 123 0.9× 49 0.4× 130 1.4× 23 0.3× 17 0.2× 26 328
María Dolores García-Prats Spain 10 114 0.9× 58 0.4× 75 0.8× 24 0.3× 115 1.6× 17 354
John Iafrate United States 10 124 0.9× 191 1.5× 78 0.9× 98 1.1× 20 0.3× 18 329
François Casteillo France 11 204 1.5× 197 1.5× 62 0.7× 10 0.1× 58 0.8× 30 366
Julie M. Batten United States 7 209 1.6× 124 1.0× 51 0.6× 77 0.9× 15 0.2× 8 369

Countries citing papers authored by Adrian von Witzleben

Since Specialization
Citations

This map shows the geographic impact of Adrian von Witzleben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian von Witzleben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian von Witzleben more than expected).

Fields of papers citing papers by Adrian von Witzleben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian von Witzleben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian von Witzleben. The network helps show where Adrian von Witzleben may publish in the future.

Co-authorship network of co-authors of Adrian von Witzleben

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian von Witzleben. A scholar is included among the top collaborators of Adrian von Witzleben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian von Witzleben. Adrian von Witzleben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
5.
Witzleben, Adrian von, Jaya Thomas, Cornelia Brunner, et al.. (2024). Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) – A single-cell RNA sequencing analysis. Oral Oncology. 159. 107107–107107. 2 indexed citations
6.
Witzleben, Adrian von, Johannes Doescher, Thomas K. Hoffmann, & Simon Laban. (2024). Immuntherapie von Kopf-Hals-Tumoren. HNO. 72(12). 850–856.
7.
Witzleben, Adrian von, Matthew J. Ellis, Gareth J. Thomas, et al.. (2023). Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103−CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease. Clinical Cancer Research. 30(1). 224–234. 10 indexed citations
8.
Eschweiler, Simon, Alice Wang, Ciro Ramírez-Suástegui, et al.. (2023). JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells. Cell Reports. 42(2). 112040–112040. 9 indexed citations
9.
Witzleben, Adrian von, et al.. (2023). Nasopharyngeal masses in adults—A retrospective analysis of 255 patients to evaluate symptoms, clinical findings, and histological results. World Journal of Otorhinolaryngology - Head and Neck Surgery. 11(1). 45–51. 1 indexed citations
10.
Witzleben, Adrian von, Urs Müller‐Richter, Katja Maurus, et al.. (2022). Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions. International Journal of Molecular Sciences. 23(24). 15835–15835. 1 indexed citations
11.
Denkinger, Michael, Dhayana Dallmeier, Peter Kühn, et al.. (2021). Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center. Cancers. 13(4). 832–832. 17 indexed citations
12.
Witzleben, Adrian von, et al.. (2021). Treatment success after rhinosurgery: an evaluation of subjective and objective parameters. European Archives of Oto-Rhino-Laryngology. 279(1). 205–211. 5 indexed citations
13.
Witzleben, Adrian von, Johannes Doescher, Marie‐Nicole Theodoraki, et al.. (2021). Influence of travel burden on tumor classification and survival of head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 278(11). 4535–4543. 2 indexed citations
14.
Witzleben, Adrian von, et al.. (2021). Infrasound a new weapon in cancer therapy?. EXPLORE. 18(3). 366–370. 5 indexed citations
15.
Witzleben, Adrian von, Chuan Wang, Simon Laban, Natalia Savelyeva, & Christian H. Ottensmeier. (2020). HNSCC: Tumour Antigens and Their Targeting by Immunotherapy. Cells. 9(9). 2103–2103. 57 indexed citations
16.
Witzleben, Adrian von, Cornelia Brunner, Johann M. Kraus, et al.. (2020). Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC). International Journal of Cancer. 148(8). 2023–2035. 10 indexed citations
17.
Marienfeld, Ralf, Kevin Mellert, Adrian von Witzleben, et al.. (2019). Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. Sarcoma. 2019. 1–10. 11 indexed citations
18.
Barth, Thomas F.E., Adrian von Witzleben, Peter Möller, & S. Scheil-Bertram. (2017). Notochordale Tumoren. Der Pathologe. 39(2). 117–124. 3 indexed citations
19.
Witzleben, Adrian von, Jochen K. Lennerz, Stephanie E. Weissinger, et al.. (2015). In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. European Spine Journal. 25(12). 4016–4024. 20 indexed citations
20.
Witzleben, Adrian von, Ralf Marienfeld, Holger Barth, et al.. (2015). Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway. Cancer Research. 75(18). 3823–3831. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026